Longboard Pharmaceuticals, Inc. - stock earnings
LBPH Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -12.9 million USD | ? USD |
| 2023Q2 | -15.0 million USD | ? USD |
| 2023Q1 | -11.0 million USD | ? USD |
| 2022Q4 | -11.0 million USD | ? USD |
| 2022Q3 | -11.3 million USD | ? USD |
| 2022Q2 | -11.4 million USD | ? USD |
| 2022Q1 | -9.6 million USD | ? USD |
| 2021Q4 | -8.8 million USD | ? USD |
| 2021Q3 | -6.3 million USD | ? USD |
| 2021Q2 | -7.0 million USD | ? USD |
| 2021Q1 | -5.7 million USD | ? USD |
| 2020Q4 | -10.1 million USD | ? USD |
| 2020Q3 | -2.6 million USD | ? USD |
| 2020Q2 | -1.6 million USD | ? USD |
| 2020Q1 | -174000 USD | ? USD |
LBPH Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -50.7 million USD | ? USD |
| 2022 | -43.1 million USD | ? USD |
| 2021 | -27.7 million USD | ? USD |
| 2020 | -14.4 million USD | ? USD |
LBPH
Price: $21.38
52 week price:
Earnings Per Share: -2.39 USD
P/E Ratio: -8.09
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 65700
Market Capitalization: 794.8 million